LatestHeadlines

Sign In

Sign In

Sign In

Takeda Pharmaceutical

First AI-generated drugs may reach market by 2030, says Insilico CEO

First AI-generated drugs may reach market by 2030, says Insilico CEO

Li Ka-Shing-backed Hutchmed sells stake in unit for US$608mil

Li Ka-Shing-backed Hutchmed sells stake in unit for US$608mil

Japan approves Novavax Covid vaccine, adding fourth option

Japan approves Novavax Covid vaccine, adding fourth option

Takeda planning biggest Japan company bond sale ever

Takeda planning biggest Japan company bond sale ever

Takeda shareholders agree to US$60 billion Shire acquisition

Takeda shareholders agree to US$60 billion Shire acquisition